ArticleHeliyon2025

Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563].

Feng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.